Glycoconjugates as vaccines for cancer immunotherapy: clinical trials and future directions.
about
Bridging innate and adaptive antitumor immunity targeting glycans.A cancer therapeutic vaccine based on clustered Tn-antigen mimetics induces strong antibody-mediated protective immunity.Combining synthetic carbohydrate vaccines with cancer cell glycoengineering for effective cancer immunotherapy.Recent development in carbohydrate-based cancer vaccines.Patented cancer vaccines: the promising leads.
P2860
Glycoconjugates as vaccines for cancer immunotherapy: clinical trials and future directions.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Glycoconjugates as vaccines fo ...... trials and future directions.
@en
Glycoconjugates as vaccines fo ...... trials and future directions.
@nl
type
label
Glycoconjugates as vaccines fo ...... trials and future directions.
@en
Glycoconjugates as vaccines fo ...... trials and future directions.
@nl
prefLabel
Glycoconjugates as vaccines fo ...... trials and future directions.
@en
Glycoconjugates as vaccines fo ...... trials and future directions.
@nl
P1476
Glycoconjugates as vaccines fo ...... trials and future directions.
@en
P2093
Alssandra Franco
P356
10.2174/187152008783330888
P577
2008-01-01T00:00:00Z